Clinical Report: The Role of Tryptophan in Prolactin's Effects on Insomnia
Overview
This study investigates the relationship between prolactin levels, tryptophan, and insomnia in perimenopausal women. It finds that higher serum tryptophan levels significantly moderate the association between prolactin and insomnia severity.
Background
Insomnia is a prevalent issue among perimenopausal women, impacting their physical health and quality of life. Understanding the neuroendocrine mechanisms behind insomnia during this transition is crucial for developing effective interventions. This study sheds light on the role of prolactin and tryptophan in this context.
Data Highlights
Measure
Correlation
Prolactin levels vs ISI scores
Positive
Tryptophan moderation effect
β = 0.227, 95% CI = 0.04–0.41, p = 0.0148
Key Findings
Insomnia is highly prevalent among perimenopausal women, affecting their quality of life.
Serum prolactin levels are positively associated with insomnia severity, anxiety, and depression.
Higher tryptophan levels strengthen the relationship between prolactin and insomnia severity.
Insomnia in perimenopausal women is linked to neuroendocrine dysregulation and hormone fluctuations.
Understanding these relationships may inform future therapeutic strategies for insomnia in this population.
Clinical Implications
Clinicians should consider the role of prolactin and tryptophan levels when assessing insomnia in perimenopausal women. Targeted interventions that address these neuroendocrine factors may improve treatment outcomes for insomnia.
Conclusion
The findings highlight the importance of serum tryptophan in moderating the effects of prolactin on insomnia in perimenopausal women, suggesting potential avenues for future research and intervention strategies.
